We are live on ! Find out more
FLGT icon

Fulgent Genetics

262 hedge funds and large institutions have $711M invested in Fulgent Genetics in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 85 increasing their positions, 81 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more call options, than puts

Call options by funds: $58.8M | Put options by funds: $50.1M

1.94% more ownership

Funds ownership: 41%42.94% (+1.9%)

5% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 81

5% less funds holding

Funds holding: 275262 (-13)

7% less capital invested

Capital invested by funds: $764M → $711M (-$53.2M)

21% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 34

Holders
262
Holders Change
-13
Holders Change %
-4.73%
% of All Funds
4.41%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
27
Increased
85
Reduced
81
Closed
34
Calls
$58.8M
Puts
$50.1M
Net Calls
+$8.71M
Net Calls Change
+$5.37M
Name Holding Trade Value Shares
Change
Change in
Stake
TG
26
TCW Group
California
$4.82M +$4.86M +88,390 New
JP Morgan Chase
27
JP Morgan Chase
New York
$4.49M +$210K +3,815 +5%
PC
28
Pavadi Capital
New York
$4.43M +$711K +12,944 +19%
First Trust Advisors
29
First Trust Advisors
Illinois
$4.23M +$1.47M +26,684 +52%
Prudential Financial
30
Prudential Financial
New Jersey
$4.01M +$1.15M +20,855 +40%
GAM
31
Gotham Asset Management
New York
$3.47M +$287K +5,217 +9%
Jane Street
32
Jane Street
New York
$3.31M -$1.44M -26,288 -30%
RA
33
Royce & Associates
New York
$3.28M -$268K -4,884 -8%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$3.26M +$254K +4,627 +8%
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$3.09M +$384K +6,990 +14%
WG
36
Winton Group
United Kingdom
$2.99M -$421K -7,662 -12%
Millennium Management
37
Millennium Management
New York
$2.7M -$12.7M -231,361 -82%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$2.52M +$41.2K +750 +2%
Swiss National Bank
39
Swiss National Bank
Switzerland
$2.5M
LPL Financial
40
LPL Financial
California
$2.42M -$47.2K -859 -2%
Goldman Sachs
41
Goldman Sachs
New York
$2.26M -$4.18M -76,132 -65%
Janus Henderson Group
42
Janus Henderson Group
United Kingdom
$2.25M +$455K +8,270 +25%
VIA
43
Vident Investment Advisory
Georgia
$2.24M +$169K +3,072 +8%
AQR Capital Management
44
AQR Capital Management
Connecticut
$2.14M +$265K +4,824 +14%
Skandinaviska Enskilda Banken (SEB)
45
Skandinaviska Enskilda Banken (SEB)
Sweden
$2.11M -$5.28M -96,099 -71%
ASN
46
Advisory Services Network
Georgia
$2.02M -$113K -2,057 -5%
Public Sector Pension Investment Board (PSP Investments)
47
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.99M +$16.5K +301 +0.8%
PI
48
Putnam Investments
Massachusetts
$1.91M -$23.7K -431 -1%
Balyasny Asset Management
49
Balyasny Asset Management
Illinois
$1.78M +$1.8M +32,702 New
MAM
50
Meeder Asset Management
Ohio
$1.76M +$340K +6,184 +24%

FLGT Hedge Fund Activity: Q2 2022 in Review

262 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q2 2022, worth a combined $711M — down 7% from $764M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of FLGT and 27 opened new positions — a net loss of 7 holders — while 81 trimmed existing stakes and 85 added.

The largest buyer was Dimensional Fund Advisors, adding an estimated $21.3M. The largest seller was Aaron Wealth Advisors, cutting an estimated $17.5M.

  • 262 institutional investors held Fulgent Genetics (FLGT) as of Q2 2022, down from 275 in Q1 2022.
  • Funds reported $711M of Fulgent Genetics stock for Q2 2022, down 7% quarter-over-quarter.
  • 27 funds opened new Fulgent Genetics positions in Q2 2022 and 34 closed out, a net change of -7 holders.
  • The largest Fulgent Genetics buyer in Q2 2022 was Dimensional Fund Advisors, an estimated $21.3M added.
  • The largest Fulgent Genetics seller in Q2 2022 was Aaron Wealth Advisors, an estimated $17.5M sold.

Based on aggregated 13F filings for Q2 2022.